Effects of icodextrin on insulin resistance and adipocytokine profiles in patients on peritoneal dialysis

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 3, 2008, Pages 243-249

  Takeguchi, Fumihiro ^a,c   Nakayama, Masaaki ^b   Nakao, Toshiyuki ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Shinjuku Ward   (Japan)

Author keywords

Adiponectin; Icodextrin; Insulin resistance; Peritoneal dialysis

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; EXTRANEAL; GLUCOSE; ICODEXTRIN; INSULIN; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; FEMALE; GLUCOSE ABSORPTION; GLUCOSE INFUSION; GLUCOSE TOLERANCE TEST; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY FUNCTION; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPOKINES; ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; DIALYSIS SOLUTIONS; FEMALE; GLUCANS; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 44349169941     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2008.00581.x     Document Type: Article

References (23)

1. Jaar BG, Coresh J, Plantinga LC et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 2005 143 : 174 83.
2. Lameire N, Bernaert P, Lambert MC, Viji D. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1994 48 (Suppl. S31 8.
3. Pyorala K, Savolainen E, Kaukola S, Haapakoshi J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factor in disease in humans and predictive value during 9, 1 /2-year follow-up of the Helsinki Policemen Study Population. Acta Med Scand Suppl 1985 701 : 38 52.
4. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979 2 : 154 60.
5. Fontbonne A, Charles MA, Thibult N et al. Hyper insulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow up. Diabetologia 1991 34 : 356 61.
6. Rigalleau V, Gin H. Carbohydrate metabolism in uraemia. Curr Opin Clin Nutr Metab Care 2005 8 : 463 9.
7. Minamikawa J, Tanaka S, Yamauchi M, Inoue D, Koshiyama H. Potent inhibitory effect of triglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab 1998 83 : 1818 20.
8. Gokal R, Moberly J, Lindholm B, Mujais S. Metabolic and laboratory effects of icodextrin. Kidney Int 2002 81 (Suppl. S62 71.
9. Amici G, Orrasch M, Da Rin G, Bocci C. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2001 17 : 80 3.
10. Furuya R, Odamaki M, Kumagai H, Hishida A. Beneficial effects of icodextrin on plasma level of adipocytokines in peritoneal dialysis patients. Nephrol Dial Transplant 2006 21 : 494 8.
11. Furuhashi M, Ura N, Higashiura K et al. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003 42 : 76 81.
12. Schupp M, Janke J, Clasen R, Unger T, Kintscher U. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 2004 109 : 2054 7.
13. Yamagishi S, Matsui T, Sato T, Takeuchi M. Protective role of pravastatin in the pathogenesis of the metabolic syndrome. Med Hypotheses 2006 66 : 609 11.
14. Yamauchi T, Kamon J, Waki H et al. The mechanisms by witch both heterozygous PPARγ deficiency and PPARγ agonist improve insulin resistance. J Biol Chem 2001 276 : 41245 54.
15. Kirpichnikov D. Metformin: an update. Ann Intern Med 2002 137 : 25 33.
16. Amery A, Birkenhager W, Brixko P et al. Glucose intolerance during diuretic therapy in elderly hypertensive patients. A second report from the European Working Party on high blood pressure in the elderly (EWPHE). Postgrad Med J 1986 732 : 919 24.
17. Tsuchida A, Yamauchi T, Ito Y et al. Insulin/foxol pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 2004 279 : 30817 22.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment. Insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 : 412 19.
19. Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW. Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 1981 19 : 564 7.
20. Rangwala SM, Lazar MA. Peroxisome proliferators-activated receptor γ in diabetes and metabolism. Trends Phamacol Sci 2004 25 : 331 6.
21. Chudek J, Adamczak M, Karkoszka H et al. Plasma adiponectin concentration before and after successful kidney transplantation. Transplant Proc 2003 35 : 2186 9.
22. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996 3 : 213 19.
23. Sisca S, Maggiore U. Beneficial Effect of Icodextrin on the Hypertriglyceridemia of CAPD Patients. Perit Dial Int 2002 22 : 727 9.